HPV-related cancers: with 5,000 new cases a year, calls to vaccinate 30-year-olds as well
Extending HPV vaccination to young women and men and integrating primary and secondary prevention: the proposal from five organisations calling for a national strategy
Key points
Over 5,000 new cases of cancer are caused by HPV infections in Italia every year: all of these cases are preventable through simple preventative measures that are already available but which need to be strengthened. There are three possible measures that need to be implemented to definitively eradicate all these cancers: these were outlined, to mark World Cervical Cancer Elimination Day, by five organisations: Lilt (Italian League for the Fight against Cancer); the IncontraDonna Foundation; ACTO Italia (Alliance Against Ovarian Cancer); Loto – Together Against Ovarian Cancer; and Cittadinanzattiva.
Requests
First and foremost, the organisations are calling for information and awareness-raising campaigns to be stepped up, targeting in particular parents, young people and the male population. Another priority is to update the National Vaccination and Immunisation Schedule to extend the HPV vaccine programme to all men and women up to the age of 30 at least. Finally, a national strategy is needed that integrates immunisation and screening in a coordinated manner, in line with international and national prevention objectives.
“The human papillomavirus (HPV) is a serious public health problem that threatens millions of men and women across the globe,” emphasise Lilt, Fondazione IncontraDonna, Acto Italia, Loto and Cittadinanzattiva. In Italia alone, there are over 2,300 new cases of cervical cancer, the vast majority of which are caused by HPV. The virus does not pose a risk exclusively to women; it is also responsible for a significant proportion of cancers of the head and neck, the anus, the vagina, the vulva and the penis. It has been estimated that up to 80 per cent of the entire sexually active population contracts the virus at least once in their lifetime. It is therefore essential to move beyond the notion that HPV prevention concerns only women; there is a need to protect as many people as possible, including men. For this reason, first and foremost, we are calling for greater awareness-raising efforts regarding a cancer risk factor that we believe is still underestimated by the majority of the public.”
Extending the vaccination programme to include those up to the age of 30
As early as 2021, the five associations, together with other signatories, had endorsed and promoted the Manifesto for the Elimination of HPV-Related Cancers. The document called for a series of measures to implement the WHO’s global strategy for the elimination of cervical cancer in Italia. The World Health Organisation has identified three targets to be achieved by 2030: at least 90 per cent of girls under 15 to be fully vaccinated against HPV; at least 70 per cent of women to undergo screening; and appropriate treatment for at least 90 per cent of women with precancerous lesions (or cervical cancer). ‘These targets can be achieved thanks, in part, to the efficiency and high quality of our National Health Service,’ the five associations continue. ‘However, an integrated and sustained approach is needed, one capable of combining both primary and secondary prevention. We believe it is essential to extend the free vaccination programme to all men and women up to the age of 30 as soon as possible.”
Coverage still insufficient
A safe, effective vaccine capable of drastically reducing the risks has been available for several years, including in our country. Vaccination coverage rates are improving, but for the various cohorts of women, we are still consistently below 75 per cent. In some regions, coverage reaches 80 per cent, which is still below the threshold set by the WHO. For boys, on the other hand, we do not reach 65 per cent, and for the ‘older’ cohorts born in 2001 and 2000, we reach just 3 per cent and 2 per cent respectively. It is clear that we need to boost vaccination rates and tackle mistrust towards these public health measures. We therefore endorse the Ministry of Health’s proposal to extend vaccination services to schools, universities and pharmacies. Greater involvement of all healthcare professionals in promoting HPV vaccination is also required.

